Lee's Pharmaceutical Holdings Limited
LPCUF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $0 |
| Revenue | $0 | $0 | $0 | – |
| % Growth | 0% | -6.3% | – | – |
| Gross Profit | $0 | $0 | $0 | – |
| % Margin | 51.8% | 51.8% | 54.3% | – |
| EBITDA | $0 | $0 | $0 | – |
| % Margin | 19.9% | 19.9% | 11.2% | – |
| Net Income | $0 | $0 | $0 | – |
| % Margin | 9.7% | 9.7% | 4.1% | – |
| EPS Diluted | 0.057 | 0.057 | 0.026 | – |
| % Growth | 0% | 119.2% | – | – |
| Operating Cash Flow | $0 | $0 | $0 | – |
| Capital Expenditures | -$0 | -$0 | -$0 | – |
| Free Cash Flow | $0 | $0 | $0 | – |